Peter Johann

Investor

Managing General Partner at NGN Capital

About

Managing General Partner at NGN Capital with a background in biotech and pharmaceutical business development, having previously held senior corporate development, licensing, and marketing roles at Boehringer Ingelheim, F. Hoffmann-La Roche, and Boehringer Mannheim. He holds a Ph.D. from the Technical University Munich and serves on several life sciences company boards including Exosome Diagnostics and Vivaldi Biosciences.

Invests in

Biotech

Investments

Board seats

Cerapedics, Inc.Endosense SAExosome Diagnostics Inc.Horizon Pharma IncJerini AGMicromet Inc.NaniRx TherapeuticsNoxxon Pharma AGResverlogix Corp.Santhera Pharmaceuticals AGVivaldi Biosciences, Inc.Zenith Epigenetics Inc.

Per the firm's website.

Colleagues at NGN Capital

Alexander Cuomo

CFO at NGN Capital

John Costantino

Managing General Partner and CFO at NGN Capital

Kenneth Abramowitz

Managing General Partner at NGN Capital

Kenneth J. Gorelick

Venture Partner at NGN Capital

William J. Gedale

Senior Advisor at NGN Capital